Latest / The Biorevolution Podcast
Big data in pharma - From garbage to gold
The biorevolution podcast #15
In our data-heavy age, data becomes a treasure, a currency, a valuable good. This is true especially for the biotech and pharmaceutical industries, where data can inform the development of novel drugs. But should own biomedical data – and where should the lines between privacy and patient benefit be drawn? In the new episode of We’re doomed, we’re saved, Andreas Horchler and Louise von Stechow discuss new strategies of data sharing and ownership in biomedicine and pharma.
Content and Editing: Louise von Stechow and Andreas Horchler
Disclaimer: Louise von Stechow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.